{"entity":{"type":"insider","cik":"0001838139","url":"/insider/0001838139","json_url":"/insider/0001838139.json","name":"Urist Marshall","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":21,"first":"2021-05-24","last":"2026-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Urist Marshall","source":"filing","n_filings":21,"first_seen":"2021-05-24","last_seen":"2026-07-02"}],"transactions":[{"id":6008941,"accession":"0001838139-26-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000022","line_url":"/filing/0001838139-26-000022#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9099.0,"shares_display":"9,099","price_per_share":55.8802,"price_display":"55.88","price_state":"stated","total_value":508453.9398,"total_display":"508,453.94","total_whole":"508,454","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":5829629,"accession":"0001838139-26-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000020","line_url":"/filing/0001838139-26-000020#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9098.0,"shares_display":"9,098","price_per_share":55.1843,"price_display":"55.18","price_state":"stated","total_value":502066.7614,"total_display":"502,066.76","total_whole":"502,067","shares_owned_after":9099.0,"shares_owned_after_display":"9,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-25","scope":"insider"},{"id":5829627,"accession":"0001838139-26-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000018","line_url":"/filing/0001838139-26-000018#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13684.0,"shares_display":"13,684","price_per_share":52.7505,"price_display":"52.75","price_state":"stated","total_value":721837.842,"total_display":"721,837.84","total_whole":"721,838","shares_owned_after":18197.0,"shares_owned_after_display":"18,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-21","scope":"insider"},{"id":6100434,"accession":"0001838139-26-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000016","line_url":"/filing/0001838139-26-000016#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13684.0,"shares_display":"13,684","price_per_share":53.0647,"price_display":"53.06","price_state":"stated","total_value":726137.3548,"total_display":"726,137.35","total_whole":"726,137","shares_owned_after":31881.0,"shares_owned_after_display":"31,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":6160022,"accession":"0001838139-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000010","line_url":"/filing/0001838139-26-000010#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":41.0905,"price_display":"41.09","price_state":"stated","total_value":821810.0,"total_display":"821,810.00","total_whole":"821,810","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":6141975,"accession":"0001838139-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000008","line_url":"/filing/0001838139-26-000008#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.2555,"price_display":"40.26","price_state":"stated","total_value":805110.0,"total_display":"805,110.00","total_whole":"805,110","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-26","scope":"insider"},{"id":5759270,"accession":"0001838139-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000006","line_url":"/filing/0001838139-26-000006#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.5173,"price_display":"39.52","price_state":"stated","total_value":790346.0,"total_display":"790,346.00","total_whole":"790,346","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":5876862,"accession":"0001838139-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000004","line_url":"/filing/0001838139-26-000004#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.7817,"price_display":"40.78","price_state":"stated","total_value":815634.0,"total_display":"815,634.00","total_whole":"815,634","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider"},{"id":5852395,"accession":"0001838139-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-26-000002","line_url":"/filing/0001838139-26-000002#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":38.4825,"price_display":"38.48","price_state":"stated","total_value":769650.0,"total_display":"769,650.00","total_whole":"769,650","shares_owned_after":80000.0,"shares_owned_after_display":"80,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-06","scope":"insider"},{"id":5179286,"accession":"0001838139-25-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-25-000014","line_url":"/filing/0001838139-25-000014#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.319,"price_display":"39.32","price_state":"stated","total_value":786380.0,"total_display":"786,380.00","total_whole":"786,380","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-26","filed_date":"2025-12-29","scope":"insider"},{"id":4971622,"accession":"0001838139-25-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-25-000012","line_url":"/filing/0001838139-25-000012#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":38.3791,"price_display":"38.38","price_state":"stated","total_value":767582.0,"total_display":"767,582.00","total_whole":"767,582","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-19","filed_date":"2025-12-22","scope":"insider"},{"id":4856358,"accession":"0001838139-25-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001838139-25-000010","line_url":"/filing/0001838139-25-000010#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":38.321,"price_display":"38.32","price_state":"stated","total_value":766420.0,"total_display":"766,420.00","total_whole":"766,420","shares_owned_after":140000.0,"shares_owned_after_display":"140,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-17","scope":"insider"},{"id":4285264,"accession":"0001838139-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001838139-25-000008","line_url":"/filing/0001838139-25-000008","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41576.0,"shares_display":"41,576","price_per_share":39.152756123725226,"price_display":"39.15","price_state":"stated","total_value":1627814.9886,"total_display":"1,627,814.99","total_whole":"1,627,815","shares_owned_after":160000.0,"shares_owned_after_display":"160,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-09","scope":"insider","n_lines":2},{"id":4744464,"accession":"0001838139-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001838139-25-000006","line_url":"/filing/0001838139-25-000006","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41575.0,"shares_display":"41,575","price_per_share":39.91554597955502,"price_display":"39.92","price_state":"stated","total_value":1659488.8241,"total_display":"1,659,488.82","total_whole":"1,659,489","shares_owned_after":183334.0,"shares_owned_after_display":"183,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":8214706,"accession":"0001209191-23-012883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-012883","line_url":"/filing/0001209191-23-012883#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23333.0,"shares_display":"23,333","price_per_share":37.2965,"price_display":"37.30","price_state":"stated","total_value":870239.2345,"total_display":"870,239.23","total_whole":"870,239","shares_owned_after":46667.0,"shares_owned_after_display":"46,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-24","scope":"insider"},{"id":6352929,"accession":"0001209191-22-043282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043282","line_url":"/filing/0001209191-22-043282#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19734.0,"shares_display":"19,734","price_per_share":43.1976,"price_display":"43.20","price_state":"stated","total_value":852461.4384,"total_display":"852,461.44","total_whole":"852,461","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-27","scope":"insider"},{"id":6352924,"accession":"0001209191-22-043282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043282","line_url":"/filing/0001209191-22-043282#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":43.0514,"price_display":"43.05","price_state":"stated","total_value":154985.04,"total_display":"154,985.04","total_whole":"154,985","shares_owned_after":19734.0,"shares_owned_after_display":"19,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider"},{"id":6699330,"accession":"0001209191-22-039294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-039294","line_url":"/filing/0001209191-22-039294#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23333.0,"shares_display":"23,333","price_per_share":43.1875,"price_display":"43.19","price_state":"stated","total_value":1007693.9375,"total_display":"1,007,693.94","total_whole":"1,007,694","shares_owned_after":23334.0,"shares_owned_after_display":"23,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-24","scope":"insider"},{"id":6117429,"accession":"0000899243-22-018222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-018222","line_url":"/filing/0000899243-22-018222#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23333.0,"shares_display":"23,333","price_per_share":39.8507,"price_display":"39.85","price_state":"stated","total_value":929836.3831,"total_display":"929,836.38","total_whole":"929,836","shares_owned_after":46667.0,"shares_owned_after_display":"46,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-16","scope":"insider"},{"id":4511558,"accession":"0000950103-21-008573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950103-21-008573","line_url":"/filing/0000950103-21-008573#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP & Co-Head of R&I)","role_mark":"O","role_mark_label":"Officer (EVP & Co-Head of R&I)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Co-Head of R&I","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16568.0,"shares_display":"16,568","price_per_share":47.0219,"price_display":"47.02","price_state":"stated","total_value":779058.8392,"total_display":"779,058.84","total_whole":"779,059","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-08","scope":"insider"},{"id":4511554,"accession":"0000950103-21-008573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-008573","line_url":"/filing/0000950103-21-008573#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP & Co-Head of R&I)","role_mark":"O","role_mark_label":"Officer (EVP & Co-Head of R&I)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Co-Head of R&I","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16566.0,"shares_display":"16,566","price_per_share":45.1323,"price_display":"45.13","price_state":"stated","total_value":747661.6818,"total_display":"747,661.68","total_whole":"747,662","shares_owned_after":16568.0,"shares_owned_after_display":"16,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider"},{"id":5040654,"accession":"0000950103-21-008458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-008458","line_url":"/filing/0000950103-21-008458#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP & Co-Head Research & Inv)","role_mark":"O","role_mark_label":"Officer (EVP & Co-Head Research & Inv)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Co-Head Research & Inv.","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14566.0,"shares_display":"14,566","price_per_share":41.5248,"price_display":"41.52","price_state":"stated","total_value":604850.2368,"total_display":"604,850.24","total_whole":"604,850","shares_owned_after":33134.0,"shares_owned_after_display":"33,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":5040650,"accession":"0000950103-21-007749","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950103-21-007749","line_url":"/filing/0000950103-21-007749#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP & Co-Head Research & Inv)","role_mark":"O","role_mark_label":"Officer (EVP & Co-Head Research & Inv)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Co-Head Research & Inv.","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":4100.0,"total_display":"4,100.00","total_whole":"4,100","shares_owned_after":47700.0,"shares_owned_after_display":"47,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-24","scope":"insider"},{"id":5040643,"accession":"0000950103-21-007749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-007749","line_url":"/filing/0000950103-21-007749#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001838139","owner_name":"Urist Marshall","owner_display_name":"Urist Marshall","owner_url":"/insider/0001838139","role":"Officer (EVP & Co-Head Research & Inv)","role_mark":"O","role_mark_label":"Officer (EVP & Co-Head Research & Inv)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Co-Head Research & Inv.","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":41.0837,"price_display":"41.08","price_state":"stated","total_value":78059.03,"total_display":"78,059.03","total_whole":"78,059","shares_owned_after":47800.0,"shares_owned_after_display":"47,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802768","name":"Royalty Pharma plc","url":"/issuer/0001802768","role":"Officer (EVP, Research & Investments)","n_filings":21,"first_seen":"2021-05-24","last_seen":"2026-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838139","retrieved_at":"2026-08-23T21:01:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}